- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis ; day:15 ; month:2 ; year:2017 ; pages:1-12
Cancer immunology immunotherapy ; (15.2.2017), 1-12
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Bergqvist, Viktoria
- Beteiligte Personen und Organisationen
-
Hertervig, Erik
Gedeon, Péter
Kopljar, Marija
Griph, Håkan
Kinhult, Sara
Carneiro, Ana
Marsal, Jan
SpringerLink (Online service)
- DOI
-
10.1007/s00262-017-1962-6
- URN
-
urn:nbn:de:1111-201703103135
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
28.07.2025, 12:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bergqvist, Viktoria
- Hertervig, Erik
- Gedeon, Péter
- Kopljar, Marija
- Griph, Håkan
- Kinhult, Sara
- Carneiro, Ana
- Marsal, Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Gut microbiota shifts from onset to remission in immune checkpoint inhibitor-induced enterocolitis: a case report
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Gut microbiota shifts from onset to remission in immune checkpoint inhibitor-induced enterocolitis: a case report
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Gut microbiota shifts from onset to remission in immune checkpoint inhibitor-induced enterocolitis: a case report
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors